Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

AstraZeneca has signed an AI-led research agreement with China’s CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...

Astra has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new ...

MPs are calling for Government investment in the A50/A500 corridor to help create 39,000 jobs and build 67,000 new homes.

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...